It's a helicopter view based on market cap.
Excluded that additional data - it's too time consuming to manually look up and transcribe additional financial data, let alone keep it up to date. I just automatically grab market cap data with a spreadsheet lookup. Somewhat annoying that financial functions in spreadsheets don't provide the additional data easily.
None of them have an active P/E ratio which means they don't have regular earnings.
Some of these companies are running trials with hundreds of patients. Mirati has over 1,000 patients in trials listed on this page https://www.mirati.com/clinical-mirati-sponsored/ and hence burning cash.
RAC have stated all along they will keep trials lean via small proof-of-concept trials to generate results to attract a partner for larger trials (buyout could be the other path). Some of these small trials could also be a pathway to approval.
(for those new here - see below - example of an approval from a 28 patient trial )
RACE Oncology Peer Analysis, page-15
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |